Literature DB >> 24613166

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: a propensity-matched comparison.

Toshihiro Fukui1, Sachiko Tanaka2, Shuichiro Takanashi3.   

Abstract

OBJECTIVE: The aim of our study was to compare the early and long-term outcomes of patients undergoing off-pump coronary artery bypass grafting (CABG) with and without previous coronary stents.
METHODS: Between September 2004 and September 2011, 269 patients with previous stents underwent first-time isolated off-pump CABG. These patients were compared with 897 patients without previous stent. A propensity score-matching analysis was performed to compare early and late outcomes between the groups. Mean follow-up time was 43.4 months after surgery.
RESULTS: Patients with previous stents were more likely to be men (85.9% in the stent group vs 79.4% in the no-stent group; P=.022) and more likely to have prior myocardial infarction (60.2% vs 36.8%; P<.001). Mean number of anastomoses was lower in patients with previous stents than in patients without previous stents (4.0 vs 4.2; P=.037). There was no difference in the use of bilateral internal thoracic artery graft between the groups (88.8% vs 89.1%; P>.999). After propensity adjustment for preoperative characteristics, both operative death (0.7% vs 1.5%; P=.414) and the major complications rates (7.8% vs 7.5%; P=.869) were similar between the groups. The actuarial survival rate at 7 years was not different between the groups (87.2%±3.2% vs 84.8%±2.9%; P=.470). Furthermore, freedom from major adverse cardiac and cerebrovascular events at 7 years were similar between the groups (78.9%±3.8% vs 77.6%±3.3%; P=.811).
CONCLUSIONS: Previous coronary stents do not increase early and long-term morbidity or mortality in patients undergoing off-pump CABG.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24613166     DOI: 10.1016/j.jtcvs.2014.02.004

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Prior percutaneous coronary intervention and outcomes in patients after coronary artery bypass grafting: a meta-analysis of 308,284 patients.

Authors:  Hongliang Zhang; Zhenyan Zhao; Jing Yao; Jie Zhao; Tao Hou; Moyang Wang; Yanlu Xu; Bincheng Wang; Guannan Niu; Yonggang Sui; Guangyuan Song; Yongjian Wu
Journal:  Ther Adv Chronic Dis       Date:  2022-05-13       Impact factor: 4.970

2.  Immediate Postoperative Complications in Patients Undergoing CABG; Investigating the Role of Prior Coronary Stenting.

Authors:  Sohrab Negargar; Shahriar Anvari; Kyomars Abbasi; Elgar Enamzadeh
Journal:  J Cardiovasc Thorac Res       Date:  2014-12-30

3.  Impact of prior coronary stenting on the outcome of subsequent coronary artery bypass grafting.

Authors:  Yu-Ting Cheng; Shao-Wei Chen; Chih-Hsiang Chang; Pao-Hsien Chu; Dong-Yi Chen; Victor Chien-Chia Wu; Kuo-Sheng Liu; Yu-Yun Nan; Feng-Chun Tsai; Pyng-Jing Lin
Journal:  Biomed J       Date:  2017-05-31       Impact factor: 4.910

4.  Does Prior Percutaneous Coronary Intervention Influence the Outcomes of Coronary Artery Bypass Surgery?

Authors:  Gade S V Miguel; Alexandre G Sousa; Gilmara S Silva; Flávia C Colósimo; Noedir A G Stolf
Journal:  Braz J Cardiovasc Surg       Date:  2020-02-01

5.  Long-term survival in patients who had CABG with or without prior coronary artery stenting.

Authors:  Pratik Rai; Rebecca Taylor; Mohamad Nidal Bittar
Journal:  Open Heart       Date:  2020-11

6.  Late Myocardial Infarction and Repeat Revascularization after Coronary Artery Bypass Grafting in Patients with Prior Percutaneous Coronary Intervention.

Authors:  Fausto Biancari; Antonio Salsano; Francesco Santini; Marisa De Feo; Magnus Dalén; Qiyao Zhang; Giuseppe Gatti; Enzo Mazzaro; Ilaria Franzese; Ciro Bancone; Marco Zanobini; Tuomas Tauriainen; Timo Mäkikallio; Matteo Saccocci; Alessandra Francica; Stefano Rosato; Zein El-Dean; Francesco Onorati; Giovanni Mariscalco
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.